F Dicenta Gisbert

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Patients undergoing cardiac transplantation are at increased risk of dyslipidemia (60% to 80%). Lipid-lowering treatment in these patients should be aggressive given the known role of dyslipidemia in chronic transplant rejection. The objective of this study was to evaluate the efficacy and safety of pravastatina therapy and its effect upon cyclosporine(More)
  • 1